Covestor Ltd - ROCKET PHARMACEUTICALS INC ownership

ROCKET PHARMACEUTICALS INC's ticker is RCKT and the CUSIP is 77313F106. A total of 164 filers reported holding ROCKET PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.

Quarter-by-quarter ownership
Covestor Ltd ownership history of ROCKET PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$060.0%0.00%
Q1 2024$06
-14.3%
0.00%
Q4 2023$07
+40.0%
0.00%
Q3 2023$05
-16.7%
0.00%
Q2 2023$060.0%0.00%
Q1 2023$06
-50.0%
0.00%
Q4 2022$012
+71.4%
0.00%
Q3 2022$07
-46.2%
0.00%
Q1 2022$013
-23.5%
0.00%
Q4 2021$0170.00%
Other shareholders
ROCKET PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
M28 Capital Management LP 665,880$10,627,00011.09%
RTW INVESTMENTS, LP 15,802,802$252,213,0005.82%
Ally Bridge Group (NY) LLC 479,506$7,653,0005.05%
TANG CAPITAL MANAGEMENT LLC 1,265,900$20,204,0002.48%
TIGER MANAGEMENT L.L.C. 279,700$4,464,0001.95%
Prosight Management, LP 200,000$3,192,0001.71%
COWEN AND COMPANY, LLC 999,588$15,953,0001.53%
Boxer Capital, LLC 1,466,051$23,398,0001.32%
Affinity Asset Advisors, LLC 267,794$4,274,0001.19%
HARBOR CAPITAL ADVISORS, INC. 66,410$1,060,0000.97%
View complete list of ROCKET PHARMACEUTICALS INC shareholders